Endokrinologie und Diabetologie-Leitlinien
54 aktuelle Endokrinologie und Diabetologie-Leitlinien von nationalen Behörden, europäischen Fachgesellschaften und HTA-Institutionen, über 15 Quellgruppen. eUvidence verankert Endokrinologie und Diabetologie-Antworten an diesen Leitlinien; jeder Eintrag verlinkt auf die eigene Seite der herausgebenden Institution.
Europäische Fachgesellschaften· 6
- Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults
ESE · European Society of Endocrinology · 2025
- WHO recommendations on care for women with diabetes during pregnancy
WHO · World Health Organization · 2025 · recommendation
- 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
ESC · European Society of Cardiology (developed in collaboration with the European Association for the Study of Diabetes) · 2023
- European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with ENSAT
ESE · European Society of Endocrinology (in collaboration with the European Network for the Study of Adrenal Tumors) · 2023
- 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management
ETA · European Thyroid Association · 2023
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the ADA and the EASD
EASD · American Diabetes Association and European Association for the Study of Diabetes · 2022 · consensus statement
Österreich· 3
- Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023)
OEDG · Osterreichische Diabetes Gesellschaft · 2023
- Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)
OEDG · Osterreichische Diabetes Gesellschaft · 2023
- Guidelines of the Austrian Diabetes Association: Summary of the update 2023
OEDG · Osterreichische Diabetes Gesellschaft · 2023
Dänemark· 2
- Hypothyroidism and Hyperthyroidism in Adults: Diagnosis, Treatment and Follow-up
DSAM · Dansk Selskab for Almen Medicin · 2025
- Pharmacological Treatment of Type 2 Diabetes
DSAM · Dansk Selskab for Almen Medicin / Dansk Endokrinologisk Selskab · 2022
Finnland· 2
- Type 2 Diabetes
Kaypa hoito · Finnish Medical Society Duodecim, the Finnish Society of Internal Medicine and the Medical Advisory Board of the Finnish Diabetes Association · 2024
- Obesity in Children, Adolescents and Adults
Kaypa hoito · Finnish Medical Society Duodecim, Finnish Association for the Study of Obesity and the Finnish Paediatric Society · 2020
Frankreich· 10
- Care pathway for the adult patient living with type 2 diabetes
HAS · Haute Autorite de Sante · 2025 · good practice guide
- Therapeutic strategy for the patient living with type 2 diabetes
HAS · Haute Autorite de Sante · 2024 · good practice guide
- Management of thyroid dysfunction in adults
HAS · Haute Autorite de Sante · 2023 · good practice guide
- Good use of osteoporosis medicines (updated recommendations)
HAS · Haute Autorite de Sante · 2023 · good practice guide
- Adult obesity: 2nd- and 3rd-level care - Part I: medical management
HAS · Haute Autorite de Sante · 2022 · good practice guide
- Exploration of thyroid pathologies in adults: relevance and quality criteria for ultrasound and ultrasound-guided fine-needle aspiration
HAS · Haute Autorite de Sante · 2021 · good practice guide
- SGLT2 inhibitors (gliflozins): recommendations to prevent the risks of diabetic ketoacidosis and Fournier's gangrene
ANSM · Agence nationale de securite du medicament et des produits de sante · 2021 · recommendation
- Podiatric disorders and diabetes: a multi-professional follow-up
HAS · Haute Autorite de Sante · 2020 · recommendation
- When and how to use SGLT2 inhibitors (gliflozins) in clinical practice
SFD · Societe Francophone du Diabete (with SFC, CNCF and SFNDT) · 2020 · consensus statement
- Re-evaluation of gliflozins (SGLT2 inhibitors)
HAS · Haute Autorite de Sante · 2020 · recommendation
Deutschland· 5
- Thyroid Nodules in Adults in Primary Care (S3 Guideline)
DEGAM · Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin · 2025
- Type 2 Diabetes (National Care Guideline, NVL)
AWMF · Bundesärztekammer, KBV, AWMF (ÄZQ) · 2024
- Therapy of Type 1 Diabetes (S3 Guideline)
DDG · Deutsche Diabetes Gesellschaft · 2023
- Diagnosis, Therapy and Follow-up of Diabetes Mellitus in Children and Adolescents (S3 Guideline)
DDG · Deutsche Diabetes Gesellschaft · 2023
- Prophylaxis, Diagnosis and Treatment of Osteoporosis in Postmenopausal Women and Men Aged 50+ (S3 Guideline)
DVO · Dachverband Osteologie · 2023
Irland· 2
- Adult Type 1 Diabetes Mellitus Version 2: National Clinical Guideline No. 17
NCEC · National Clinical Effectiveness Committee, Department of Health · 2024
- Adult Type 1 Diabetes Mellitus (Version 2) — National Clinical Guideline No. 17
NCEC · National Clinical Effectiveness Committee, Department of Health · 2024
Italien· 5
- Diagnosis and Treatment of Obesity in the Adult Population
SIO · Societa Italiana dell'Obesita · 2025
- Therapy of type 2 diabetes mellitus
SNLG · Sistema Nazionale Linee Guida - Istituto Superiore di Sanita · 2025
- Diagnosis and treatment of obesity in the adult population
SNLG · Sistema Nazionale Linee Guida - Istituto Superiore di Sanita · 2025
- Treatment of Overweight and Obesity Resistant to Behavioural Treatment in Adults with Metabolic Comorbidities
AME · Associazione Medici Endocrinologi · 2023
- Therapy of Type 2 Diabetes Mellitus
SID-AMD · Societa Italiana di Diabetologia / Associazione Medici Diabetologi · 2022
Niederlande· 4
- Thyroid disorders
NHG · Nederlands Huisartsen Genootschap · 2025 · good practice guide
- Fracture prevention
NHG · Nederlands Huisartsen Genootschap · 2024 · good practice guide
- Attention to adrenal insufficiency after adrenalectomy
FMS · Federatie Medisch Specialisten · 2024
- Diabetes mellitus type 2
NHG · Nederlands Huisartsen Genootschap · 2018 · good practice guide
Norwegen· 2
- National Clinical Guideline for Diabetes
Helsedir · Norwegian Directorate of Health · 2025
- National Clinical Guideline for Gestational Diabetes
Helsedir · Norwegian Directorate of Health · 2023
Polen· 4
- Clinical recommendations for the management of people with diabetes 2026 — position of Diabetes Poland
PTD · Polskie Towarzystwo Diabetologiczne (Diabetes Poland) · 2026
- 2025 Guidelines on the Management of Patients with Diabetes
PTD · Polskie Towarzystwo Diabetologiczne · 2025
- Diagnosis and Treatment of Thyroid Cancer in Adult Patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update
PTE · Polskie Towarzystwo Endokrynologiczne · 2022 · recommendation
- Thyroid Diseases in Pregnancy: Guidelines of the Polish Society of Endocrinology
PTE · Polskie Towarzystwo Endokrynologiczne · 2021
Portugal· 4
- Organisation of Health Care for People with Type 1 Diabetes Mellitus
DGS · Direção-Geral da Saúde · 2024
- Diagnosis and Classification of Diabetes Mellitus
DGS · Direcao-Geral da Saude · 2011
- Treatment of Type 2 Diabetes Mellitus: Metformin
DGS · Direcao-Geral da Saude · 2011
- Insulin Therapy in Type 2 Diabetes Mellitus
DGS · Direcao-Geral da Saude · 2011
Spanien· 2
- Clinical Practice Guideline on Type 1 Diabetes Mellitus
GuiaSalud · Servicio de Evaluacion del Servicio Canario de la Salud / Ministerio de Sanidad · 2026
- Spanish Guideline for the Comprehensive and Multidisciplinary Management of Obesity in Adults (GIRO)
SEEDO · Sociedad Espanola para el Estudio de la Obesidad · 2025
Schweden· 2
- National Guidelines for Care of Obesity
Socialstyrelsen · National Board of Health and Welfare · 2023
- National Guidelines for Diabetes Care - Support for Governance and Management
SoS · Socialstyrelsen (Swedish National Board of Health and Welfare) · 2018
Vereinigtes Königreich· 1
- Type 2 diabetes in adults: management (NG28)
NICE · National Institute for Health and Care Excellence · 2015
Suchen Sie ein bestimmtes Land? Österreich, Dänemark, Finnland, Frankreich, Deutschland, Irland.